
Hims & Hers Health Inc
NYSE:HIMS

Intrinsic Value
The intrinsic value of one
HIMS
stock under the Base Case scenario is
27.87
USD.
Compared to the current market price of 54.83 USD,
Hims & Hers Health Inc
is
Overvalued by 49%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Hims & Hers Health Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Hims & Hers Health Inc
Balance Sheet Decomposition
Hims & Hers Health Inc
Current Assets | 447m |
Cash & Short-Term Investments | 322.7m |
Receivables | 6.9m |
Other Current Assets | 117.3m |
Non-Current Assets | 444.7m |
PP&E | 217.9m |
Intangibles | 161.2m |
Other Non-Current Assets | 65.7m |
Free Cash Flow Analysis
Hims & Hers Health Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Hims & Hers Health Inc
Revenue
|
1.8B
USD
|
Cost of Revenue
|
-409.6m
USD
|
Gross Profit
|
1.4B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
115.6m
USD
|
Other Expenses
|
48.8m
USD
|
Net Income
|
164.4m
USD
|
HIMS Profitability Score
Profitability Due Diligence
Hims & Hers Health Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Hims & Hers Health Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
HIMS Solvency Score
Solvency Due Diligence
Hims & Hers Health Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Score
Hims & Hers Health Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HIMS Price Targets Summary
Hims & Hers Health Inc
According to Wall Street analysts, the average 1-year price target for
HIMS
is 43.48 USD
with a low forecast of 25.25 USD and a high forecast of 89.25 USD.
Dividends
Current shareholder yield for HIMS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HIMS
stock under the Base Case scenario is
27.87
USD.
Compared to the current market price of 54.83 USD,
Hims & Hers Health Inc
is
Overvalued by 49%.